Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development

Renal cell carcinoma (RCC) is one of the leading causes of death in men. Messenger ribonucleic acid (mRNA) vaccines may be an attractive means to achieve satisfactory results. Cancer immunotherapy is a promising cancer treatment strategy. However, immunotherapy is not widely used in renal cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xinglin, Zhang, Tongtong, Zhai, Xinyu, Wan, Zhong, Ge, Minyao, Liu, Chengzong, Tan, Mingyue, Xu, Dongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669058/
https://www.ncbi.nlm.nih.gov/pubmed/36405755
http://dx.doi.org/10.3389/fimmu.2022.1037808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669058/
https://www.ncbi.nlm.nih.gov/pubmed/36405755
http://dx.doi.org/10.3389/fimmu.2022.1037808

Ejemplares similares